Search

Immune Therapies for Hematologic Disorders

Recently the treatment of hematological and solid malignancies has been revolutionized by the introduction of novel immunotherapeutic strategies.

Read more

EHA-AHA Joint membership

We are pleased to inform that EHA and the Armenian Hematology Association (AHA) have joined forces and are offering you the possibility of an EHA-AHA Joint Membership in 2023.

Read more

EHA-SFH Joint membership

We are pleased to inform that EHA and the Société Française d’Hématologie (SFH) have joined forces and are offering you the possibility of an EHA-SFH Joint Membership in 2024.

Read more

EHA-SRH Joint membership

We are pleased to inform that EHA and the Societatea Română de Hematologie (SRH) have joined forces and are offering you the possibility of an EHA-SRH Joint Membership in 2023.

Read more

EHA-EMN Joint Session at the European Myeloma Network Meeting EMN2023

On Saturday, 22 April, EHA and EMN brought together patients, regulators and clinicians to discuss Novel Endpoints in Multiple Myeloma.

Read more

Sponsor prospectus

Dear Partner,

Welcome to the digital EHA Sponsor Prospectus 2024-2025. Over the past two years, the world of congresses, meetings, and education has drastically changed.

Read more

Health data

Health data plays a substantial role in the European Union’s strategic, legislative, and funding initiatives in the health domain.

Read more